Global Medtech Guidance Tracker: December 2020
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-seven guidance documents have been posted on the tracker since its last update.
You may also be interested in...
Four out of 10 of Medtech Insight's top EU stories were dominated by news related to the implications for medtech of the UK’s final break from the EU on 31 December. But no one should ignore the pressure that implementation of the new EU medtech regulations is causing.
The end of a calendar year is a chance to reflect on times past and the future, to make resolutions and look ahead to changes for the better. With Brexit in mind, the turn of 2020 is a time to prophesize on UK medtech’s immediate future.
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.